PKU HealthCare Corp.,Ltd. (000788.SZ)
CNY 6.94
(0.43%)
CNY 6.94
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 121.84 Million | 278.89 Million | 59.14 Million | -68.14 Million | -5.78 Million | 204.37 Million |
| Net Income | 44.35 Million | 55.79 Million | 43.14 Million | 39.17 Million | 49.88 Million | 45.02 Million |
| Depreciation & Amortization | 51.12 Million | 47.98 Million | 43.19 Million | 18.63 Million | 16.68 Million | 15.83 Million |
| Deferred income taxes | 3.61 Million | -1.16 Million | -2.51 Million | -566.35 Thousand | -2.62 Million | -141.51 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.8 Million | 145.9 Million | -98.92 Million | -191.31 Million | -123.79 Million | 112.26 Million |
| Other non-cash items | 6.98 Million | 29.21 Million | 71.72 Million | 65.36 Million | 51.44 Million | 31.25 Million |
| Investing Cash Flow | -81.78 Million | -35.33 Million | -45.4 Million | -58.08 Million | -40.77 Million | -36.91 Million |
| Investments in PPE | -63.19 Million | -35.32 Million | -45.4 Million | -58.09 Million | -41.41 Million | -37.08 Million |
| Acquisitions | 195.92 Thousand | 1.2 Million | - | 3300.49 | 639.6 Thousand | 166.53 Thousand |
| Investment purchases | -20 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.21 Million | -1.21 Million | - | -58.09 Million | -41.41 Million | 166.53 Thousand |
| Financing Cash Flow | -207.64 Million | -92.44 Million | -31.09 Million | -74.75 Million | 158.65 Million | -43.41 Million |
| Debt repayment | -91.35 Million | -70.98 Million | -33.3 Million | -117.54 Million | -141.9 Million | -154.8 Million |
| Dividends payments | -3.87 Million | -27.57 Million | -19.3 Million | -13.52 Million | -11.91 Million | -18.51 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -112.41 Million | 6.11 Million | 21.51 Million | 56.3 Million | 325.43 Million | 129.9 Million |
| Accounts receivables | -59.87 Million | 133.23 Million | -177.12 Million | -73.64 Million | -198.03 Million | 2.86 Million |
| Accounts payables | - | -133.23 Million | 177.12 Million | 73.64 Million | 198.03 Million | - |
| Inventory | -12.01 Million | -46.6 Million | -21.22 Million | 36.39 Million | 20.18 Million | 31.73 Million |
| Other working capital | 70.07 Million | 192.5 Million | -77.7 Million | -227.71 Million | -143.98 Million | 80.53 Million |
| Cash at beginning of period | 513.51 Million | 362.39 Million | 379.74 Million | 580.73 Million | 468.61 Million | 344.52 Million |
| Cash at end of period | 345.92 Million | 513.51 Million | 362.39 Million | 379.74 Million | 580.73 Million | 468.61 Million |
| Capital Expenditure | -63.19 Million | -35.32 Million | -45.4 Million | -58.09 Million | -41.41 Million | -37.08 Million |
| Effect of forex changes on cash | 0.09 | 0.44 | -0.11 | 1181.09 | 16.09 Thousand | 44.48 Thousand |
| Net cash flow / Change in cash | -167.58 Million | 151.11 Million | -17.35 Million | -200.98 Million | 112.11 Million | 124.09 Million |
| Free Cash Flow | 58.64 Million | 243.57 Million | 13.74 Million | -126.23 Million | -47.19 Million | 167.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 43.53 Million | 42.77 Million | 44.04 Million | 44.35 Million | -1.79 Million | 14.39 Million |
| Depreciation & Amortization | - | 12.61 Million | 12.61 Million | 51.12 Million | 12.54 Million | -25.39 Million |
| Deferred income taxes | - | - | - | 3.61 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -24.25 Million | - | 1.8 Million | -71.88 Million | 121.62 Million |
| Other non-cash items | -31.25 Million | 62 Million | -84.64 Million | 6.98 Million | 153.7 Million | -21.5 Million |
| Investing Cash Flow | -6.28 Million | -9.69 Million | -1.67 Million | -81.78 Million | -23.95 Million | -25.47 Million |
| Investments in PPE | -6.28 Million | -9.87 Million | -1.67 Million | -63.19 Million | -25.33 Million | -5.49 Million |
| Acquisitions | - | 185.84 Thousand | - | 195.92 Thousand | 166.82 Thousand | 20 Thousand |
| Investment purchases | - | - | - | -20 Million | - | -20 Million |
| Sales/Maturities of investments | - | - | - | - | - | 19.98 Million |
| Other Investing Activities | - | 185.84 Thousand | - | 1.21 Million | 1.21 Million | -19.98 Million |
| Financing Cash Flow | -51.24 Million | -5.29 Million | -5.4 Million | -207.64 Million | -8.61 Million | -29.39 Million |
| Debt repayment | -32 Million | - | - | -91.35 Million | -5.57 Million | -78.04 Million |
| Dividends payments | -15.81 Million | -355.73 Thousand | -351.86 Thousand | -3.87 Million | -365.19 Thousand | -379.78 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -35.43 Million | -4.94 Million | -5.04 Million | -112.41 Million | -2.66 Million | 49.02 Million |
| Accounts receivables | - | 13.19 Million | - | -59.87 Million | -59.87 Million | 57.2 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -37.45 Million | - | -12.01 Million | -12.01 Million | 64.41 Million |
| Other working capital | - | - | - | 70.07 Million | - | - |
| Cash at beginning of period | 375.43 Million | 298.25 Million | 345.92 Million | 513.51 Million | 239.12 Million | 204.86 Million |
| Cash at end of period | 330.17 Million | 375.43 Million | 298.25 Million | 345.92 Million | 345.92 Million | 239.12 Million |
| Capital Expenditure | -6.28 Million | -9.87 Million | -1.67 Million | -63.19 Million | -25.33 Million | -5.49 Million |
| Effect of forex changes on cash | - | - | - | 0.09 | -0.06 | -0.03 |
| Net cash flow / Change in cash | -45.25 Million | 77.17 Million | -47.67 Million | -167.58 Million | 106.8 Million | 34.25 Million |
| Free Cash Flow | 5.99 Million | 82.28 Million | -42.27 Million | 58.64 Million | 114.03 Million | 83.63 Million |
CGL
301006
1770
LRCDF
300686
AREXMIS